Skip to main content
OpenTrials
Completed

NCT Number: NCT03958175

The Alouette Test in Parkinson Disease

Reading disorders in Parkinson's Disease (PD) are poorly evaluated due to the lack of validated tests to screen for them. They are often attributed to hand tremors associated with the disease. In this study, the investigating team evaluated the "alouette test" validated for dyslexia screening, in PD by comparing the results to healthy patients.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with Parkinson's Disease
  • Montreal Cognitive Assessment (MoCA) test > 20

Exclusion criteria

  • Patient's with supranuclear Palsy
  • Other neurologic disease
  • Any ophthalmologic disease
  • Presence of a nystagmus
  • Visual acuity < 0.6

Treatment and study plan

Alouette test (reading test)

Other

The alouette test was assessed at a fixed distance of 40 centimeters on a fixed surface to avoid errors related to hand tremors.

Primary outcomes

  1. Score on the Alouette test

    Time frame: 1 day

    The Alouette test is based on the precision and speed in reading a short text (279 words). The score corresponds to the total number of words correctly read.

Sponsors and collaborators

Lead sponsor

Hospices Civils de Lyon

Other

Registry information

Official study title

Screening for Reading Difficulties in Parkinson's Disease: An Evaluation of the Alouette Test

Acronym: REPEAT

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
May 21, 2019
Registry last updated
May 21, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.